Bronchodilators and exercise in COPD
Part of Lungs & breathing clinical trials.
This study tests how a bronchodilator (a medicine that opens airways) affects breathing and exercise in people with COPD. It aims to understand if it helps you breathe easier during physical activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD.
- You are 40 years or older.
- You are a current or former smoker with at least a 20 pack-year history (for example, smoking one pack a day for 20 years).
- Your lung function tests show air trapping (too much air stays in your lungs).
- You have shortness of breath during daily activities.
- You have not had a COPD flare-up in the last 6 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the volume of air you breathe in during a bronchodilator test affects response and lung airflow distribution in people with COPD. It may help improve how this routine test is done.
This study looks at how different breathing tests (spirometry and impulse oscillometry) and a simple shortness-of-breath scale relate to how well you respond to a quick-relief inhaler (bronchodilator). It aims to improve how we measure treatment effectiveness in people with asthma or COPD.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This study compares two types of breathing exercise devices to see which one helps people with COPD improve their breathing. You will use one of the devices during the study, and your lung function will be measured to see how well it works.
This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.
This Phase 2 trial tests whether sildenafil tablets can improve exercise ability, shortness of breath, and heart-lung function in people with COPD. It also compares against people without COPD to better understand how sildenafil affects breathing tests.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.